A-Z Index
Image Cart
              

 Information For:

Manufacturers

Regulator

Healthcare

Consumers

Members


Tamsulosin Hydrochloride Capsules: Notice of Intent to Revise

Date Posted: April 8, 2009
Targeted Official Date: Revision Bulletin, Date To Be Determined
Expert Committee: General Chapters-Biopharmaceutics

In accordance with section 9.05(c) of the Rules and Procedures of the 2005-2010 Council of Experts, the Biopharmaceutics Expert Committee intends to add a new Dissolution test to the Tamsulosin Hydrochloride Capsules Monograph to reflect the approved marketed products.

It is anticipated that the proposed revisions will be published as a Revision Bulletin pursuant to section 9.02(d) of the Rules and Procedures.

Should you have questions, please contact Margareth Marques, Ph.D. (301-816-8106 or ).

What's New

Changes to the Dissolution Performance Verification Test (11/20/09)

PF 35(6) Errata (10/30/09)

New official Text for October: 15 Revisions Bulletins (10/30/09)

Pending Standards for the month of October (10/30/09)

PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09)

Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09)

Elemental Impurities Hot Topics information updated (10/13/09)

General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09)

Heparin Hot Topics information updated (10/02/09)

PF Redesign

Related Resources